cotinine has been researched along with Schizophrenia in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 19 (52.78) | 29.6817 |
| 2010's | 15 (41.67) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chand, PK; Gandhi, S; Jayarajan, D; Muliyala, KP; Murthy, P; Rajalu, BM; Sharma, P; Thirthalli, J | 1 |
| Beebe, LH; Parker, CR | 1 |
| Fehsel, K; Henning, U; Korth, C; Luckhaus, C; Schäble, S; Silva, MA; Trossbach, SV; Winterer, G | 1 |
| Amiaz, R; Boules, S; Davis, JM; Guidotti, A; Jin, H; Lajtha, A; Li, C; Liu, Y; Maayan, L; Ren, J; Sershen, H; Si, TM; Smith, RC; Weiser, M; Youseff, M | 1 |
| Bacanu, SA; Boomsma, DI; Chen, J; Chen, X; Farrer, L; Gelernter, J; Jia, P; Kaprio, J; Kendler, KS; Kranzler, HR; Milaneschi, Y; Minica, C; Munafò, M; Penninx, BW; Pool, R; Tyndale, RF; Vink, JM; Ware, JJ; Yu, H; Zhao, Z | 1 |
| Brown, AS; Cheslack-Postava, K; Hinkka-Yli-Salomäki, S; McKeague, IW; Niemelä, S; Sourander, A; Surcel, HM | 1 |
| Bahn, S; Bulger, E; Craddock, MR; Guest, P; Herberth, M; Koethe, D; Krzyszton, DN; Leweke, FM; Schwarz, E | 1 |
| Dickerson, FB; Monson, ET; Origoni, AE; Severance, EG; Stallings, CR; Sullens, A; Yolken, RH | 1 |
| Buccafusco, JJ; Terry, AV | 1 |
| George, TP; Rabin, RA; Sacco, KA | 1 |
| Costa, E; Davis, JM; Guidotti, A; Lajtha, A; Maloku, E; Sershen, H; Smith, RC; Zhubi, A | 1 |
| Benowitz, NL; Gandhi, KK; Williams, JM | 1 |
| Kaplan, GB; Reid, N; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
| Benowitz, NL; Cottler, B; Gandhi, KK; Kumar, S; Lu, SE; Steinberg, ML; Williams, JM | 1 |
| Benowitz, NL; Gandhi, KK; Lu, SE; Steinberg, ML; Williams, JM | 2 |
| Brinkmeyer, J; Clepce, M; Dahmen, N; Diaz-Lacava, A; Frommann, I; Gallinat, J; Gründer, G; Kiefer, F; Lennertz, L; Maier, W; Majic, T; Mobascher, A; Mössner, R; Musso, F; Nothnagel, M; Nürnberg, P; Petrovsky, N; Quednow, BB; Savary, N; Spreckelmeyer, KN; Thiele, H; Thuerauf, N; Toliat, MR; Wagner, M; Wienker, TF; Winterer, G | 1 |
| Brinkmeyer, J; Drusch, K; Fisahn, K; Lowe, A; Mobascher, A; Musso, F; Ohmann, C; Shah, J; Warbrick, T; Winterer, G; Wölwer, W | 1 |
| Dahmen, N; Drees, J; Ettinger, U; Frommann, I; Heilmann, K; Kessler, H; Landsberg, MW; Lennertz, L; Maier, W; Mössner, R; Petrovsky, N; Quednow, BB; Sträter, B; Wagner, M | 1 |
| Infante, M; Khandat, A; Kloos, A; Singh, A; Smith, RC | 1 |
| Higgins, ST; O'Neill, SC; Tidey, JW | 1 |
| Court, JA; Davis, KL; Haroutunian, VH; Long, P; Martin-Ruiz, CM; Perry, EK; Young, AH | 1 |
| Bozikas, VP; Fokas, K; Gabrieli, C; Gamvrula, K; Kafantari, A; Kanaze, FI; Karavatos, A; Melissidis, P; Niopas, I | 1 |
| Nybäck, H; Strand, JE | 1 |
| Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Cooper, TB; de Leon, J; Diaz, FJ; Josiassen, RC; Simpson, GM | 1 |
| Keshavan, MS; Reddy, RD; Yao, JK | 1 |
| Abanyie, F; Benowitz, NL; Foulds, J; Steinberg, ML; Williams, JM; Ziedonis, DM | 1 |
| Butler, E; Kelly, E; Khan, A; Matute, M; Smith, RC; Vaidhyanathaswamy, S; Warner-Cohen, J | 1 |
| Hejza, J; Kleszczewska, E; Kleszczewski, T | 1 |
| Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Beauverie, P; Castéra, S; Dagorne, O; de Beaurepaire, R; Espaze, R; Falissard, B; Giroult, P; Houery, M; Lukasiewicz, M; Mahuzier, G; Matheron, I; Molimard, R; Niel, P; Padovani, P; Poisson, N; Richier, JP; Rocher, J; Ruetsh, O; Touzeau, D; Visinoni, A | 1 |
| Benowitz, NL; Foulds, J; Gandhi, KK; Steinberg, ML; Williams, JM; Ziedonis, DM | 1 |
| Fawzi, MH; Fawzi, MM; Khedr, HH | 1 |
| Hori, H; Kakihara, S; Nakamura, J; Sugita, A; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Reddy, R; van Kammen, DP; Yao, JK | 1 |
10 trial(s) available for cotinine and Schizophrenia
| Article | Year |
|---|---|
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
Topics: Adult; Antipsychotic Agents; Cognition; Cotinine; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Psychological Tests; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Symptom Assessment; Tobacco Use Cessation Devices; Varenicline | 2016 |
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.
Topics: Adult; Behavior Therapy; Behavior, Addictive; Breath Tests; Bupropion; Carbon Monoxide; Combined Modality Therapy; Cotinine; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Patient Dropouts; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Rapid smoking may not be aversive in schizophrenia.
Topics: Adult; Carbon Monoxide; Cotinine; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 2013 |
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.
Topics: Adult; Analysis of Variance; Cognition Disorders; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Self Report; Smoking; Social Behavior; Statistics as Topic; Stress, Psychological; Young Adult | 2013 |
Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cotinine; Cross-Over Studies; Double-Blind Method; Electrooculography; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reaction Time; Saccades; Schizophrenia; Smoking; Statistics as Topic; Young Adult | 2013 |
Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
Topics: Administration, Intranasal; Adult; Analysis of Variance; Blood Pressure; Cognition; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotine; Schizophrenia; Smoking; Treatment Outcome | 2002 |
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Breath Tests; Carbon Monoxide; Cotinine; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation | 2002 |
Does clozapine decrease smoking?
Topics: Adult; Antipsychotic Agents; Biomarkers; Clozapine; Cotinine; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Sex Characteristics; Smoking; Time Factors | 2005 |
Effects of nicotine nasal spray on cognitive function in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Blood Pressure; Carbon Monoxide; Cognition; Cotinine; Double-Blind Method; Female; Heart Rate; Humans; Linear Models; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Space Perception | 2006 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
26 other study(ies) available for cotinine and Schizophrenia
| Article | Year |
|---|---|
Self-reported tobacco use and urine cotinine levels in persons with schizophrenia.
Topics: Biomarkers; Cotinine; Humans; Schizophrenia; Self Report; Smoking; Tobacco Use | 2020 |
Descriptions and correlates of salivary cotinine in individuals with schizophrenia spectrum disorders.
Topics: Adult; Cotinine; Female; Humans; Male; Middle Aged; Pilot Projects; Saliva; Schizophrenia; Smoking; Young Adult | 2013 |
Peripheral DISC1 protein levels as a trait marker for schizophrenia and modulating effects of nicotine.
Topics: Animals; Brain; Cotinine; Female; Flow Cytometry; Gene Expression Regulation; Humans; Lymphocytes; Male; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Regression Analysis; Schizophrenia; Tobacco Use Disorder | 2014 |
Genetic Relationship between Schizophrenia and Nicotine Dependence.
Topics: Cotinine; Female; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Schizophrenia; Signal Transduction; Tobacco Use Disorder | 2016 |
Prenatal Nicotine Exposure and Risk of Schizophrenia Among Offspring in a National Birth Cohort.
Topics: Adolescent; Adult; Case-Control Studies; Cohort Studies; Cotinine; Female; Finland; Humans; Nicotine; Odds Ratio; Pregnancy; Prenatal Exposure Delayed Effects; Registries; Risk Factors; Schizophrenia; Smoking; Statistics as Topic; Tobacco Use Disorder; Young Adult | 2016 |
Differential effects on T-cell function following exposure to serum from schizophrenia smokers.
Topics: Adult; Antigens, CD; Cell Proliferation; Cotinine; Female; Humans; Interleukin-2; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Statistics, Nonparametric; T-Lymphocyte Subsets; Time Factors; Young Adult | 2010 |
Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes.
Topics: alpha7 Nicotinic Acetylcholine Receptor; C-Reactive Protein; Cotinine; Enzyme-Linked Immunosorbent Assay; Humans; Lymphocytes; Nicotine; Protein Isoforms; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Smoking; Transcription, Genetic | 2009 |
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.
Topics: Animals; Antipsychotic Agents; Benzylidene Compounds; Cognition Disorders; Conditioning, Operant; Cotinine; Female; Hallucinogens; Ketamine; Macaca nemestrina; Male; Memory; Nicotinic Agonists; Pyridines; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology | 2009 |
Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.
Topics: Acoustic Stimulation; Adult; Analysis of Variance; Cotinine; Executive Function; Female; Humans; Male; Middle Aged; Neural Inhibition; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Reaction Time; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Smoking; Statistics as Topic; Time Factors | 2009 |
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
Topics: Benzazepines; Cotinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Gene Expression; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; RNA, Messenger; Schizophrenia; Smoking Cessation; Varenicline | 2010 |
Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Carbamazepine; Cotinine; Cytochrome P-450 CYP2A6; Enzyme Induction; Female; Humans; Male; Middle Aged; Nicotine; Oxcarbazepine; Schizophrenia; Smoking; Valproic Acid; Young Adult | 2010 |
Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.
Topics: Adult; Age Factors; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Sex Factors; Smoking; Surveys and Questionnaires | 2011 |
Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating.
Topics: Adult; Analysis of Variance; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cotinine; Electroencephalography; Evoked Potentials, Auditory; Female; Gene Frequency; Genotype; Geography; Germany; Humans; Linkage Disequilibrium; Male; Polymorphism, Single Nucleotide; Risk Factors; Schizophrenia; Sensory Gating; Smoking; Transcription Factor 4; Transcription Factors | 2012 |
Nicotine intake and smoking topography in smokers with bipolar disorder.
Topics: Adult; Antimanic Agents; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Case-Control Studies; Cotinine; Cytochrome P-450 CYP2A6; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking | 2012 |
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
Topics: Aged; Aged, 80 and over; Bridged Bicyclo Compounds, Heterocyclic; Case-Control Studies; Cotinine; Dementia; Female; Humans; Male; Middle Aged; Nicotine; Prefrontal Cortex; Psychiatric Status Rating Scales; Pyridines; Radioligand Assay; Receptors, Nicotinic; RNA, Messenger; Schizophrenia; Severity of Illness Index; Smoking | 2003 |
No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
Topics: Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Cotinine; Female; Humans; Male; Middle Aged; Reference Values; Schizophrenia; Smoking | 2005 |
Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls.
Topics: Adult; Biomarkers; Cotinine; Humans; Indicators and Reagents; Inpatients; Interviews as Topic; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Reference Values; Saliva; Schizophrenia; Schizophrenic Psychology; Smoking | 2005 |
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking | 2005 |
Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.
Topics: Adult; Amino Acids, Essential; Antipsychotic Agents; Chromatography, Gas; Cotinine; Docosahexaenoic Acids; Erythrocyte Membrane; Fatty Acids, Unsaturated; Female; Humans; Male; Schizophrenia | 2004 |
Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.
Topics: Adult; Cotinine; Demography; Female; Humans; Male; Middle Aged; Nicotine; Psychotic Disorders; Regression Analysis; Schizophrenia; Smoking | 2005 |
[Determination of cadmium level in passive tobacco smokers schizophrenia patients].
Topics: Adult; Cadmium; Comorbidity; Cotinine; Humans; Middle Aged; Schizophrenia; Smoking; Tobacco Smoke Pollution | 2006 |
Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients.
Topics: Adolescent; Adult; Alcoholism; Comorbidity; Cotinine; Female; gamma-Glutamyltransferase; Humans; Illicit Drugs; Male; Mental Disorders; Middle Aged; Personality Disorders; Schizophrenia; Schizophrenic Psychology; Smoking; Statistics as Topic; Substance Abuse Detection; Substance-Related Disorders; Transferrin; Truth Disclosure | 2007 |
Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia.
Topics: Adult; Analysis of Variance; Carbon Monoxide; Cotinine; Female; Flavoring Agents; Humans; Male; Menthol; Nicotine; Schizophrenia; Tobacco Use Disorder | 2007 |
Tobacco smoking in Egyptian schizophrenia patients with and without obsessive-compulsive symptoms.
Topics: Adult; Age of Onset; Ambulatory Care; Comorbidity; Cotinine; Developing Countries; Egypt; Female; Humans; International Classification of Diseases; Male; Nicotiana; Obsessive-Compulsive Disorder; Prevalence; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors; Smoking; Tobacco Use Disorder | 2007 |
Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
Topics: Adult; Aged; Antipsychotic Agents; Caffeine; Chromatography, High Pressure Liquid; Coffee; Cotinine; Drinking; Female; Humans; Male; Middle Aged; Pilot Projects; Prevalence; Risperidone; Schizophrenia; Smoking | 2008 |
Reduced level of plasma antioxidant uric acid in schizophrenia.
Topics: Adult; Antioxidants; Antipsychotic Agents; Cotinine; Haloperidol; Humans; Male; Schizophrenia; Smoking; Uric Acid | 1998 |